Researchers from Iwate Medical University and Tohoku University have revealed that it is possible to predict cancer relapse and treatment response by measuring circulating tumor DNA (ctDNA), in tandem ...

A research team proposes a method to assess cancer patients for their likelihood to either respond to treatment or relapse.

Ear, nose, and throat (ENT) infections are one of the most common reasons for prescribing antibiotics to children. Although ...

Strickland Metals has a busy start to 2025, with Serbian gold assays expected next week and a maiden resource in February ...

Discover effective methods to determine the gravimetric sample composition of mixtures with unknown constituents, ensuring ...

The UK-based firm has issued five Class II recalls for its RX-series analyzers since 2018 for issues related to reagent carryover between subsequent tests.

James Stunt, the former son-in-law of F1 tycoon Bernie Ecclestone, is one of five men on trial over an alleged ...

Sirios Resources Inc. (TSX-V: SOI; OTCQB: SIREF) is a Quebec-based mineral exploration company focused on developing its 100% ...

NYSE:DHR) Beckman Coulter Introduces Cutting-Edge Research Use Only Assays for Neurodegenerative Disease Research ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, will provide an update to the investment community, ...

Ultrasensitive ctDNA detection with NeXT Personal shows 81% sensitivity in early-stage lung adenocarcinoma, improving ...